Evotec SE (EVOTF)
OTCMKTS
· Delayed Price · Currency is USD
8.58
0.00 (0.00%)
At close: Jul 11, 2025
Evotec SE Employees
Evotec SE had 4,740 employees as of December 31, 2024. The number of employees decreased by 321 or -6.34% compared to the previous year.
Employees
4,740
Change (1Y)
-321
Growth (1Y)
-6.34%
Revenue / Employee
$178,755
Profits / Employee
-$46,940
Market Cap
1.46B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4,740 | -321 | -6.34% |
| Dec 31, 2023 | 5,061 | 109 | 2.20% |
| Dec 31, 2022 | 4,952 | 754 | 17.96% |
| Dec 31, 2021 | 4,198 | 626 | 17.53% |
| Dec 31, 2020 | 3,572 | 542 | 17.89% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Endo, Inc. | 3,116 |
| Tian'an Technology Group | 8 |
| Elite Pharmaceuticals | 68 |
| Glass House Brands | 374 |
| CytoDyn | 9 |
| American Oncology Network | 1,914 |
| Northwest Biotherapeutics | 25 |
| Silence Therapeutics | 116 |
Evotec SE News
- 18 days ago - Evotec's Collaboration Sparks Hope For Acute Kidney Injury Breakthroughs - Benzinga
- 18 days ago - Evotec Joins NURTuRE-AKI Consortium to Gain Multi-Omics-Based Molecular Understanding of Acute Kidney Injury - Accesswire
- 2 months ago - Evotec Receives $ 2.5 m Grant to Generate Next Generation Tuberculosis Treatments - Accesswire
- 2 months ago - Evotec SE 2025 Q1 - Results - Earnings Call Presentation - Seeking Alpha
- 2 months ago - Evotec SE (EVO) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Evotec SE Reports Q1 2025 results: Paving the Way for 2025 Growth in Soft Market Environment - Accesswire
- 2 months ago - Earnings Preview: Evotec - Benzinga
- 2 months ago - Evotec SE to Announce Results for the First Quarter 2025 on 6 May 2025 - Accesswire